Antimicrobial activities of gatifloxacin against nosocomial isolates of Stenotrophomonas maltophilia measured by MIC and time-kill studies

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 7, 2001, Pages 2126-2128

  Cohn, M L ^a   Waites, K B ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GATIFLOXACIN; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; TIMENTIN;

AGAR GEL DIFFUSION; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; STENOTROPHOMONAS MALTOPHILIA;

ANTI-INFECTIVE AGENTS; CROSS INFECTION; FLUOROQUINOLONES; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; STENOTROPHOMONAS MALTOPHILIA; TIME FACTORS;

EID: 0034954626     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.7.2126-2128.2001     Document Type: Article

References (13)

1. Antimicrobial activity of gatifloxacin against Stenotrophomonas maltophilia and Burkholderia species
2. Levofloxacin in vitro activity and time-kill evaluation of Stenotrophomonas maltophilia clinical isolates
3. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia
4. Susceptibility of Stenotrophomonas maltophilia to moxifloxacin, trovafloxacin, ofloxacin, and ciprofloxacin
5. Xanthomonas maltophilia bacteremia: An analysis of 32 cases
6. In vitro susceptibility of Xanthomonas (Pseudomonas) maltophilia to newer antimicrobial agents
7. Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro
8. Susceptibilities of 123 strains of Xanthomonas maltophilia to eight β-lactams (including β-lactam-β-lactamase inhibitor combinations) and ciprofloxacin tested by five methods
9. Typing of 154 clinical isolates of Stenotrophomonas maltophilia by pulsed-field gel electrophoresis and determination of the in vitro susceptibilities of these strains to 28 antibiotics
10. A changing pattern of susceptibility of Xanthomonas maltophila to antimicrobial agents: Implications for therapy
11. Risk factors for epidemic Xanthomonas maltophilia infection/colonisation in intensive care unit patients
12. A study to determine the pharmacokinetics and inflammatory fluid penetration of gatifloxacin following a single oral dose